Paeds Cases · clinical-pharmacology-and-therapeutics
Counselling a family about a medicine the child cannot take — OSCE
Communication OSCE on reframing a child's erratic disease control as a formulation-and-adherence problem, assessing how the medicine is actually taken, identifying the barrier, and co-designing a formulation and regimen plan with the family, including escalation to the pharmacist for an age-appropriate alternative.
On this page
Study tools
Target exams
Counselling a family about a medicine the child cannot take — OSCE
Station overview
A communication station testing whether the candidate can reframe a child's erratic disease control as a formulation-and-adherence problem, assess how the medicine is actually taken without blame, identify the barrier, and co-design a plan with the family and the pharmacist — without escalating the chronic dose (the classic error after a non-adherence-driven problem). The station is not about the pharmacology of tacrolimus per se; it is about the swallow, the taste, the regimen, and the shared plan. [2]
References4ShowHide
- [1]Nunn T Formulation of medicines for children. Br J Clin Pharmacol, 2005.PMID 15948931
- [2]Dean AJ A systematic review of interventions to enhance medication adherence in children and adolescents with chronic illness. Arch Dis Child, 2010.PMID 20522463
- [3]Mennella JA Optimizing oral medications for children. Clin Ther, 2008.PMID 19108800
- [9]Münch J, Sessler I, Bosse HM, et al. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children. Pharmaceutics, 2023.PMID 37376177